Concern about kidney injury linked to contaminated syrup- and liquid-based medicines in children News item 05 November 2022 Pages: 1 - 1
EMA recommendations for reducing risk of serious JAK inhibitor AEs News item 05 November 2022 Pages: 2 - 2
EMA recommends market withdrawal of amfepramone for safety reasons News item 05 November 2022 Pages: 3 - 3
Iodinated contrast media-related hypothyroidism in neonates and infants News item 05 November 2022 Pages: 4 - 4
No pregnancy complications after use of mRNA COVID-19 vaccines News item 05 November 2022 Pages: 5 - 5
Risk of EVUSHELD treatment failure due to antiviral resistance News item 05 November 2022 Pages: 6 - 6
Baricitinib- and tofacitinib-related risk of VTE and cardiovascular events Clinical study 05 November 2022 Pages: 7 - 7
Insufficient compliance with valproate prescribing conditions in France Clinical study 05 November 2022 Pages: 9 - 9
Interferon-based therapy increases risk of autoimmune thyroid diseases Clinical study 05 November 2022 Pages: 10 - 10
Risks of thrombosis and thromboembolic events after first COVID-19 vaccination Clinical study 05 November 2022 Pages: 11 - 11
SGLT2i use increases risk of postoperative diabetic ketoacidosis Clinical study 05 November 2022 Pages: 12 - 12
Voriconazole-related hepatotoxicity in Chinese patients Clinical study 05 November 2022 Pages: 13 - 13